| 價格 | 詢價 | ||
| 包裝 | 100ug | 500ug | 1000ug |
| 最小起訂量 | 100ug |
| 發(fā)貨地 | 北京 |
| 更新日期 | 2026-06-30 |
| 中文名稱:TGF-beta RI蛋白 | 英文名稱:TGF-beta RI |
| 品牌: 百普賽斯 | 產(chǎn)地: 北京 |
| 保存條件: -20°C to -70°C | 純度規(guī)格: 99.9% |
| 產(chǎn)品類別: 重組蛋白 | |
| 貨號: TGF-beta RI | 用途范圍: 科研 |
| 規(guī)格: 100ug | 是否進(jìn)口: 否 |
分子別名(Synonym)
TGFR-1, ALK-5, TGF-beta receptor type-1, Activin receptor-like kinase 5
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human TGF-beta RI Protein, Fc Tag (TG1-H5254) is expressed from human 293 cells (HEK293). It contains AA Leu 34 - Leu 126 (Accession # P36897-1).
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 36.7 kDa. The protein migrates as 43-48 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method / rFC method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

背景介紹
TGF type I receptor also called the activin receptor-like kinase 5 (ALK5) and involved in TGF signaling. TGFβ signaling is mediated by the interaction of TGFβ ligands (TGFβ 1, 2 or 3) with cell surface receptors, the TGF type I, type II and type III receptors. Signaling is initiated by binding of TGF to the TGF type II receptor forming a ligand-receptor complex which interacts with the TGF type I receptor.
| 成立日期 | 2010-07-22 (17年) | 注冊資本 | 8000萬人民幣 |
| 員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 | 經(jīng)營模式 | 工廠,試劑 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP4年
|
武漢佰樂博生物技術(shù)有限公司
|
2026-07-30 | |
| ¥3300 |
VIP1年
|
上海撫生實業(yè)有限公司
|
2026-07-30 | |
| ¥3300 |
VIP2年
|
上海西格生物科技有限公司
|
2026-07-30 |